Loading…
Biotech Next Gen 2021 has ended
Back To Schedule
Wednesday, June 23 • 9:30am - 10:25am
New trends shaping biopharma manufacturing

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Feedback form is now closed.
COVID-19 put pharma manufacturing front-and-center last year, but for many in the know, the production revolution was already underway. Whether it’s the rise of cell and gene therapies, the sudden, intense demand for pandemic vaccines and therapeutics, or the push to make essential medicines at home, the landscape is changing for contractors and drugmakers alike. We’ll discuss the latest tech—from self-contained production modules and continuous manufacturing to robotics and virtual reality—with the companies and experts leading the charge into the next manufacturing frontier.

Moderator
avatar for Fraiser Kansteiner

Fraiser Kansteiner

Staff Writer, Fierce Pharma
Fraiser Kansteiner is a staff writer at Fierce Pharma. He joined the Fierce team in 2020 and covers topics such as manufacturing, COVID-19 and drug delivery. He also manages Fierce Biotech and Fierce Pharma’s LinkedIn showcase pages. Before diving into pharma reporting, Fraiser... Read More →

Speakers
avatar for Samuel Neill, Ph.D.

Samuel Neill, Ph.D.

Business Development Director – Grand Challenges 3 and 4 Medicines Manufacturing Innovation Centre, CPI
Sam is a proactive and dynamic business development professional with over 17 years’ experience and is part of the team at CPI’s 'Medicines Manufacturing Innovation Centre' (MMIC). The MMIC is a collaboration between CPI, the University of Strathclyde and founding industry partners... Read More →
avatar for Atul Dubey, Ph.D.

Atul Dubey, Ph.D.

Director, Pharmaceutical Continuous Manufacturing, USP Reference Standards Labs
Atul Dubey is the Director of Pharmaceutical Continuous Manufacturing (PCM) at the United States Pharmacopeial Convention (USP). Headquartered in Rockville, MD, USA, USP is committed to global public health and quality of medicines for 200 years.At USP, his group is focused on supporting... Read More →
avatar for Alison Moore, Ph.D.

Alison Moore, Ph.D.

Chief Technical Officer, Allogene
Allison Moore, Ph.D., is the Chief Technical Officer for Allogene, overseeing product sciences, supply chain, manufacturing, quality and technical operations. Alison has extensive experience in all aspects of biomanufacturing and CMC product development, working in both operations... Read More →


Wednesday June 23, 2021 9:30am - 10:25am EDT
Virtual